Boehme et al., 2017 - Google Patents
Anticoagulation control in patients with ventricular assist devicesBoehme et al., 2017
View PDF- Document ID
- 7314850909657895075
- Author
- Boehme A
- Pamboukian S
- George J
- Beasley T
- Kirklin J
- Tallaj J
- Dillon C
- Levitan E
- Griffin R
- McGwin Jr G
- Hillegass W
- Limdi N
- Publication year
- Publication venue
- ASAIO Journal
External Links
Snippet
Anticoagulation control has been associated with risk of thromboembolism and hemorrhage. Herein, we explore the relationship between anticoagulation control achieved in left ventricular assist device (LVAD) patients and evaluate the association with risk of …
- 230000002429 anti-coagulation 0 title abstract description 54
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Boehme et al. | Anticoagulation control in patients with ventricular assist devices | |
| Sanfilippo et al. | Bivalirudin for alternative anticoagulation in extracorporeal membrane oxygenation: a systematic review | |
| Sabate et al. | Impact of preemptive fibrinogen concentrate on transfusion requirements in liver transplantation: a multicenter, randomized, double‐blind, placebo‐controlled trial | |
| Aggarwal et al. | Are blood stream infections associated with an increased risk of hemorrhagic stroke in patients with a left ventricular assist device? | |
| Sharma et al. | Modern use of extracorporeal life support in pregnancy and postpartum | |
| Stulak et al. | Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device | |
| Fecher et al. | The pathophysiology and management of hemorrhagic shock in the polytrauma patient | |
| Bishop et al. | Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center | |
| Yoshihara et al. | National trends in the utilization of blood transfusions in total hip and knee arthroplasty | |
| Guimbretière et al. | Prognostic impact of blood product transfusion in VA and VV ECMO | |
| Woods et al. | The association between perioperative allogeneic transfusion volume and postoperative infection in patients following lumbar spine surgery | |
| McCartney et al. | Je hovah's W itnesses and cardiac surgery: a single institution's experience | |
| Samuel et al. | Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study | |
| Steiner et al. | Antithrombotic therapy in a prospective trial of a pediatric ventricular assist device | |
| Deatrick et al. | Outcomes of venovenous extracorporeal membrane oxygenation when stratified by age: how old is too old? | |
| Halder et al. | Time in therapeutic range for left ventricular assist device patients anticoagulated with warfarin: a correlation to clinical outcomes | |
| Augustin et al. | Association between chronic kidney disease and blood transfusions for knee and hip arthroplasty surgery | |
| Gosselin et al. | Coagulation profile of liquid‐state plasma | |
| Pieri et al. | Primary anticoagulation with bivalirudin for patients with implantable ventricular assist devices | |
| Roman et al. | Techniques and applications of perioperative therapeutic plasma exchange | |
| Chapin | Von Willebrand disease in the elderly: clinical perspectives | |
| Copeland et al. | Results with an anticoagulation protocol in 99 SynCardia total artificial heart recipients | |
| Boehme et al. | Predictors of thromboembolic events in patients with ventricular assist device | |
| Macaluso et al. | Time in therapeutic range significantly impacts survival and adverse events in destination therapy patients | |
| Russell et al. | Thromboembolic and bleeding events in ICU patients with COVID‐19: A nationwide, observational study |